Nasal High-Flow Nebulization for Lung Drug Delivery: Theoretical, Experimental, and Clinical Application
Authors:
- 1 December 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Vol. 32 (6) , 341-351
Abstract
The use of nasal high-flow (NHF) therapy is rapidly spreading across acute care facilities. This raises the question of optimal delivery of inhaled medication to patients undergoing this noninvasive ventilatory support consisting in delivering heated and humidified high gas flow rates through nasal cannulas. In this article, we review experimental and clinical work evaluating the delivery of inhaled medication within the NHF circuit to target the lung without interrupting the ventilatory support. Using vibrating mesh nebulizers placed immediately upstream or downstream of the humidification chamber, with flow rates of 30–45 L/min in adults and 2–6 L/min in children and infants, about 1%–10% of the drug charged in the nebulizer may be delivered to the lungs. Compared with conventional facemask aerosol interfaces, this amount is significantly lower than amounts delivered to adults (i.e., up to 25% of the nominal dose), but similar to amounts delivered to children and infants, the latter having a predominantly nasal breathing. However, significant clinical effects have been shown in both populations when delivering bronchodilators through NHF. This interface is particularly well tolerated and may be useful to improve aerosol therapy tolerance in the pediatric setting. Thus, among patients undergoing NHF therapy, bronchodilators may be delivered through this route. Whereas other drugs may be delivered this way or if there is a patient-centered benefit to specifically use NHF for aerosol therapy among patients without ongoing ventilatory support, requires further evaluation and technological development.Keywords
This publication has 55 references indexed in Scilit:
- Improving the Lung Delivery of Nasally Administered Aerosols During Noninvasive Ventilation—An Application of Enhanced Condensational Growth (ECG)Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2011
- Influence of particle size on regional lung deposition – What evidence is there?International Journal of Pharmaceutics, 2011
- What the pulmonary specialist should know about the new inhalation therapiesEuropean Respiratory Journal, 2011
- Influence of Jet Nebulization and Oxygen Delivery on the Fraction of Inspired Oxygen: An Experimental ModelJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2009
- Air Humidity May Influence the Aerosol Distribution of Normal Saline Administered by Closed or Vented Nebulizers Operated Continuously or DosimetricallyJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2009
- Aerosol Delivery through Nasal Cannulas: An In Vitro StudyJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2008
- Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasisChronic Respiratory Disease, 2008
- In Vitro Experiments and Numerical Simulations of Airflow in Realistic Nasal Airway GeometryAnnals of Biomedical Engineering, 2006
- Evaluation of Nebulizer Performance under Various Humidity ConditionsJournal of Aerosol Medicine, 2005
- Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation.Thorax, 1993